Prothena Stock Quote 0Y3M - Stock Price, News, Charts, Message Board, Trades

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

14.65

Bid

0.00

Ask

0.00

Volume

0.00

0.00 Day's Range 0.00

14.65 52 Week Range 14.65

Market Cap

786.441M

Previous Close

14.65

Open

Last Trade

16.9024

(O)

Last Trade Time

15:57:39

Financial Volume

VWAP

Average Volume (3m)

1,319

Shares Outstanding

53,682,000

Dividend Yield

PE Ratio

-5.29

Earnings Per Share (EPS)

-2.74

Revenue

91.37M

Net Profit

-147.03M

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.prothena.com

Headquarters

Dublin, Irl

Founded

Prothena Corporation Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker 0Y3M. The last closing price for Prothena was $14.65. Over the last year, Prothena shares have traded in a share price range of $ 14.65 to $ 14.65.

Prothena currently has 53,682,000 shares outstanding. The market capitalization of Prothena is $786.44 million. Prothena has a price to earnings ratio (PE ratio) of -5.29.

Prothena to Report Third Quarter 2022 Financial Results on November 3rd

Prothena to Report Third Quarter 2022 Financial Results on November 3rd DUBLIN, Ireland, Oct. 27, 2022 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical...

Prothena to Participate in Upcoming Healthcare Conferences

Prothena to Participate in Upcoming Healthcare Conferences DUBLIN, Ireland, Sept. 01, 2022 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology...

Prothena Announces Appointment of Biotechnology Industry Leader Helen S. Kim to its Board of Directors

Prothena Announces Appointment of Biotechnology Industry Leader Helen S. Kim to its Board of Directors DUBLIN, Ireland, Sept. 01, 2022 (GLOBE NEWSWIRE) -- Prothena Corporation plc...

Prothena Reports Second Quarter 2022 Financial Results and Business Highlights

Prothena Reports Second Quarter 2022 Financial Results and Business Highlights Net cash used in operating and investing activities was $35.5 million in the second quarter and $72.9 million...

Prothena Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Prothena Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) DUBLIN, Ireland, Aug. 02, 2022 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical...

Prothena to Report Second Quarter 2022 Financial Results on August 8th

Prothena to Report Second Quarter 2022 Financial Results on August 8th DUBLIN, Ireland, Aug. 01, 2022 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical...

Prothena Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Prothena Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) DUBLIN, Ireland, July 01, 2022 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical...

Prothena to Participate in Jefferies Healthcare Conference

Prothena to Participate in Jefferies Healthcare Conference DUBLIN, Ireland, June 02, 2022 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology...

Prothena Reports First Quarter 2022 Financial Results and Business Highlights

Prothena Reports First Quarter 2022 Financial Results and Business Highlights Net cash used in operating and investing activities was $37.4 million in the first quarter; quarter-end cash and...

Prothena to Report First Quarter 2022 Financial Results on May 5th

Prothena to Report First Quarter 2022 Financial Results on May 5th DUBLIN, Ireland, April 28, 2022 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical...

Period	Open	High	Low	Avg. Daily Vol	VWAP
1	14.65	14.65	14.65	374	14.65	DE
4	14.65	14.65	14.65	458	14.65	DE
12	14.65	14.65	14.65	1319	14.65	DE
26	14.65	14.65	14.65	1137	14.65	DE
52	14.65	14.65	14.65	1050	14.65	DE
156	14.65	14.65	14.65	394	14.65	DE
260	14.65	14.65	14.65	256	14.65	DE

0Y3M - Frequently Asked Questions (FAQ)

What is the current Prothena share price?

The current share price of Prothena is $ 14.65

How many Prothena shares are in issue?

Prothena has 53,682,000 shares in issue

What is the market cap of Prothena?

The market capitalisation of Prothena is USD 786.44M

What is the 1 year trading range for Prothena share price?

Prothena has traded in the range of $ 14.65 to $ 14.65 during the past year

What is the PE ratio of Prothena?

The price to earnings ratio of Prothena is -5.29

What is the cash to sales ratio of Prothena?

The cash to sales ratio of Prothena is 8.51

What is the reporting currency for Prothena?

Prothena reports financial results in USD

What is the latest annual turnover for Prothena?

The latest annual turnover of Prothena is USD 91.37M

What is the latest annual profit for Prothena?

The latest annual profit of Prothena is USD -147.03M

What is the registered address of Prothena?

The registered address for Prothena is 77 SIR JOHN ROGERSON’S QUAY, BLOCK C, GRAND CANAL DOCKLANDS, DUBLIN, D02 VK60

What is the Prothena website address?

The website address for Prothena is www.prothena.com

Which industry sector does Prothena operate in?

Prothena operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
XSGXeros Technology Group Plc	0.725p (38.10%)	12.81M
SYMESupply@me Capital Plc	0.0034p (23.64%)	54.98M
GFINGfinity Plc	0.0675p (22.73%)	6.59M
OBDOxford Biodynamics Plc	0.60p (20.00%)	246.02M
STXShield Therapeutics Plc	3.35p (17.54%)	7.11M
TRCThe Revel Collective Plc	0.175p (-22.22%)	3.07M
KRPZKropz Plc	0.90p (-21.74%)	127.58k
PRDPredator Oil & Gas Holdings Plc	4.40p (-19.27%)	17.31M
ROQRoquefort Therapeutics Plc	2.25p (-15.09%)	472.1k
AXLArrow Exploration Corp.	19.75p (-13.19%)	3.8M
NTVONativo Resources Plc	0.0017p (0.00%)	479.88M
OBDOxford Biodynamics Plc	0.60p (20.00%)	246.02M
WBIWoodbois Limited	0.0825p (0.00%)	223.54M
MSMNMosman Oil And Gas Limited	0.041p (-5.75%)	187.69M
EMEEmpyrean Energy Plc	0.145p (-7.94%)	116.02M